Articles By Richard Conway
RA ILD: Stepping out of the shadows
By Richard Conway
09 June 2021
Despite being relatively common and frequently severe, RA-ILD has been a neglected area of research and indeed of clinical management in RA. In recent years we finally seem to have started making some progress in this area and this momentum has continued with a several interesting abstracts at EULAR 2021. Here are four selected for review.
Read Article
Turning the Corner on CV Risk in Rheumatoid Arthritis
By Richard Conway
03 June 2021
Cardiovascular (CV) disease remains the leading cause of mortality in rheumatoid arthritis (RA). A number of studies progressed our knowledge in the session Rheumatoid arthritis - comorbidity and clinical aspects – I on Thursday at EULAR 2021.
Read Article
The tantalising prospect of glucocorticoid-free treatments for systemic vasculitis
By Richard Conway
30 November 2020
Glucocorticoids are a highly effective treatment in systemic vasculitis but are also a significant cause of long-term harm in the form of treatment related adverse events.
Read Article
The folly of dietary restriction in contemporary gout?
By Richard Conway
19 November 2020
Gout has historically been considered a disease of the financially rich, rich in diet, and rich in alcohol.
Read Article